Home / Resources / The Pharmaceutical Industry: 2024 (and Beyond) Predictions

The Pharmaceutical Industry: 2024 (and Beyond) Predictions

Article
研究開発支援サービス
PDF preview of the 2024 Pharmaceutical Industry Predictions by Citeline.

Do your 2024 predictions for the pharmaceutical industry align with ours? Read on to find out.


Rubber will meet the road on diversity in 2024.
Ashley Schwalje, Senior Director of Clinical Solution Consulting, Citeline
Related products
Sitetrove Diversity Module
Sitetrove Diversity Module
スポンサーが治験責任医師の選択を最適化し、より迅速に多様性の目標を達成することが可能となる
Building a data driven site and investigator selection model
Sitetrove
グローバルな臨床試験の治験責任医師と治験実施施設の情報を提供する、業界をリードするスイート
Supporting across your entire product lifecycle
リアルワールドデータソリューション
3億人の米国市民に関する多様でトークン化されたリアルワールドのデータセットを活用して、臨床試験の計画と実施を患者中心の視点で行ってください。

Related resources

PDF preview of the "RWD More than Acronym" article.
OCT 09, 2023
Article

RWD: More Than Just Another Acronym

Real-world data holds the power to impact patient outcomes. Read our article on RWD benefits and how it impacts the patient journey.

''
MAR 01, 2023
Whitepaper
研究開発支援サービス

Unlocking the Potential of Decentralized Clinical Trials

While trials with decentralized attributes have grown, we are still in the early stages of adapting trial design strategies to better fit this new reality.

A diverse group of people looking up.
NOV 15, 2023
Article
研究開発支援サービス

3 Ways Clinical Trial Diversity Can Put Sponsors On Top

Since the FDA’s draft guidance in 2022, the industry has redoubled its efforts to incorporate diversity at pivotal points in the clinical trial process.

View all resources